Paleogenomics: How Ancient DNA Is Reshaping Modern

What Is Paleogenomics and Why Does It Matter for Medicine?

Paleogenomics combines archaeology, genetics, and clinical research by extracting and sequencing DNA from skeletal remains, teeth, and preserved tissues that can be hundreds or even thousands of years old. The field's foundational techniques were developed by Svante Pääbo, who received the 2022 Nobel Prize in Physiology or Medicine for sequencing the Neanderthal genome and demonstrating gene flow between extinct hominins and modern humans. His work showed that ancient DNA could be reliably recovered and analyzed, opening the door to large-scale studies of past populations.

For medicine, paleogenomics offers something no clinical trial can: a long-term view of how pathogens and the human immune system have co-evolved. By comparing ancient and modern genomes, researchers can identify genetic variants that were selected in response to historical epidemics. These same variants often influence susceptibility to autoimmune disease, inflammatory conditions, and infectious illness today, providing clues that may inform vaccine design, immune therapies, and prevention strategies.

How Are Ancient Mass Graves Used to Study Disease?

Mass graves and large communal burial sites are particularly valuable to paleogenomics because they often capture a snapshot of a single event or short period, allowing researchers to study an entire community at once. From these contexts, scientists have recovered DNA from Yersinia pestis, the bacterium responsible for plague pandemics including the Black Death, as well as Mycobacterium tuberculosis and Mycobacterium leprae. A widely cited 2022 study published in Nature by Klunk and colleagues analyzed DNA from victims of the 14th-century Black Death and identified immune-related variants that appeared to confer survival advantage and remain present in modern European populations.

Skeletal analysis adds another layer of evidence. Trauma patterns, growth disruption, and signs of chronic infection visible on bones help researchers distinguish violent death, malnutrition, and epidemic disease. When combined with genomic data, this paleopathological approach can reveal whether a community died from infection, conflict, or environmental stress, and it provides modern public-health researchers with rare data on how specific pathogens behaved before antibiotics, vaccines, and modern sanitation existed.

What Can Modern Patients Learn from Ancient DNA Studies?

Many of the immune variants that protected ancestors against historical pathogens have trade-offs. Variants that increased survival during plague or tuberculosis epidemics, for example, are also associated with elevated risk for conditions such as Crohn's disease, rheumatoid arthritis, and other inflammatory disorders. Understanding this evolutionary background can help clinicians and researchers interpret population-level differences in disease prevalence and tailor research priorities for immune-modulating therapies.

Paleogenomics also informs surveillance of emerging infections. By reconstructing the genomes of ancient pathogens, scientists can track how virulence factors and antibiotic-resistance precursors evolved long before modern drug use. This historical baseline strengthens current efforts by the World Health Organization and national public-health agencies to anticipate how respiratory, vector-borne, and zoonotic pathogens may adapt in the future. For patients, the practical takeaway is that genetic susceptibility to infection and immune disease is not random — it reflects a deep history that modern medicine is only beginning to read.